Identification of novel bone-specific molecular targets of binge alcohol and ibandronate by transcriptome analysis.
- Authors
- Himes, Ryan; Wezeman, Frederick H; Callaci, John J
- Year
- 2008
- Journal
- Alcoholism, clinical and experimental research
- PMID
- 18537941
- DOI
- 10.1111/j.1530-0277.2008.00736.x
- PMCID
- PMC2728683
BACKGROUND: Our laboratory established that binge alcohol-related bone damage is prevented by aminobisphosphonates, suggesting bone resorption increases following binge exposure. We examined the effects of binge alcohol and antiresorptive therapy on the relationship between bone damage and modulation of the vertebral transcriptome, in an attempt to determine how alcohol-induced bone damage and its prevention modulate bone-related biological pathways. METHODS: Male Sprague-Dawley rats were assigned to 1 of 6 treatment groups (n = 12/group). (C1) saline ip 3 d/wk for 1 week, (A1) binge alcohol, 3 g/kg, ip 3 d/wk for 1 week, (C4) saline ip, 3 d/wk for 4 weeks, (A4) binge alcohol, ip, 3 g/kg 3 d/wk for 4 weeks, (I4) ibandronate, saline ip 3 d/wk for 4 weeks, plus a single ip injection of ibandronate at 120 microg/animal, and (AI4) binge alcohol plus ibandronate as above. After 1 or 4 weeks, adjacent lumbar vertebrae were assayed for bone damage or transcriptional changes. RESULTS: Bone loss was not observed after 1 week of binge alcohol treatment. After 4 weeks, binge alcohol decreased vertebral BMD by 23% (p < 0.05) and compressive strength by 18% compared to saline controls (p < 0.05). Concurrent ibandronate prevented bone loss, increasing these parameters by 145 and 134% respectively compared to binge alcohol. (p < 0.05). Analysis of the vertebral transcriptome identified gene clusters specific for acute and chronic binge alcohol-related bone damage. Acute binge alcohol modulated the expression of integrin signaling-specific genes, while chronic binge alcohol modulated canonical Wnt signaling gene expression. Ibandronate normalized the expression of approximately 20% of the genes affected by chronic binge alcohol, allowing the identification of a unique subset of alcohol-sensitive, ibandronate-responsive genes. CONCLUSIONS: Identification of bone-specific gene expression clusters associated with acute and chronic binge alcohol treatment allowed for the identification of cellular pathways affected by binge treatment with known involvement in bone remodeling (Integrin, Canonical Wnt signaling) not previously identified as alcohol-sensitive. This data provides a basis for a plausible mechanistic explanation for the known detrimental effects of alcohol on bone formation and resorption.
No figures extracted from this document.
| Name | Type |
|---|---|
| 1700-microarray analyzer local | drug |
| A1 local | cohort |
| A1 treatment group local | cohort |
| A4 local | cohort |
| A4 treatment group local | cohort |
| ABI chemiluminescence detection kit local | drug |
| ABI chemiluminescent RT-IVT labeling kit local | drug |
| ABI microarray analyzer software package local | drug |
| ABI rat genome survey microarray local | drug |
| Acute binge alcohol local | drug |
| Acute Binge Alcohol Exposure Treatment Group local | cohort |
| Acute binge alcohol treatment local | cohort |
| Acute binge alcohol treatment local | phenotype |
| acute binge exposure local | drug |
| Adipocyte local | phenotype |
| Agilent 2100 Bioanalyzer | drug |
| AI4 local | cohort |
| AI4 treatment group local | cohort |
| AI treatment group local | cohort |
| alcohol | phenotype |
| Alcohol-modulated bone gene cluster local | gene |
| Alcohol plus ibandronate (AI) treatment group local | cohort |
| Alcohol-related bone damage local | phenotype |
| alcohol-related bone loss local | phenotype |
| Alcohol-related bone loss local | phenotype |
| Alcohol-related osteopenia local | phenotype |
| alcohol withdrawal | phenotype |
| animals | cohort |
| Applied Biosystems 1700 Gene Expression Array System local | drug |
| B2M local | gene |
| Binge Alcohol local | drug |
| Binge alcohol and ibandronate-treated local | cohort |
| Binge alcohol-treated local | cohort |
| Binge Alcohol Treated Animals local | cohort |
| binge alcohol treatment local | cohort |
| binge alcohol treatment local | drug |
| binge alcohol treatment local | phenotype |
| Bisphosphonate local | drug |
| blood alcohol level | phenotype |
| blood alcohol levels | phenotype |
| BMD | phenotype |
| body weight | phenotype |
| body weight increase local | phenotype |
| Bone architecture local | phenotype |
| Bone cement local | drug |
| bone damage local | phenotype |
| Bone Damage local | phenotype |
| Bone formation local | phenotype |
| bone loss | phenotype |
| Bone mass local | phenotype |
| Bone Metabolism local | phenotype |
| bone mineral density | phenotype |
| Bone mineral density (BMD) local | phenotype |
| Bone Remodeling local | phenotype |
| bone resorption | phenotype |
| bone strength local | phenotype |
| Bone strength local | phenotype |
| C1 local | cohort |
| C4 treatment group local | cohort |
| Cancellous BMD local | phenotype |
| Cancellous bone mineral density local | phenotype |
| Canonical Wnt signaling pathway local | drug |
| cDNA | drug |
| Chemokine/cytokine signaling local | phenotype |
| Chondrocyte local | phenotype |
| chronic binge alcohol local | drug |
| Chronic binge alcohol local | drug |
| Chronic binge alcohol group local | cohort |
| chronic binge alcohol-treated rats local | cohort |
| Chronic binge alcohol-treated rats local | cohort |
| Chronic binge alcohol treatment local | cohort |
| Chronic binge alcohol treatment local | drug |
| Chronic Binge Alcohol Treatment Group local | cohort |
| CO2 | drug |
| Compressive strength local | phenotype |
| Compressive Strength local | phenotype |
| Condition | phenotype |
| control animals | cohort |
| control group | cohort |
| control rats | cohort |
| Cortical bone mineral density local | phenotype |
| Crohn's disease | phenotype |
| CTNNB1 | gene |
| Digoxigenin-UTP-labeled cRNA local | drug |
| DKK1 | gene |
| Estrogen-dependent bone loss local | phenotype |
| ethanol consumption | phenotype |
| Fatty bone marrow local | phenotype |
| female rats | cohort |
| Fifth lumbar vertebra local | phenotype |
| food intake | phenotype |
| Fourth lumbar vertebra local | phenotype |
| fragmentation buffer | drug |
| genes | gene |
| High bone mass phenotype (HBM) local | phenotype |
| hybridization buffer local | drug |
| ibandronate local | drug |
| Ibandronate local | drug |
| Ibandronate-treated local | cohort |
| integrin | drug |
| Integrin signaling local | phenotype |
| integrin signaling genes local | gene |
| Itgav local | gene |
| Itgb3 local | gene |
| ITGB3 local | gene |
| L3 vertebrae local | phenotype |
| L4 vertebral body local | phenotype |
| L5 vertebral body local | phenotype |
| LRP5 | gene |
| LRP6 local | gene |
| lumbar vertebrae local | phenotype |
| male rats | cohort |
| Mesenchymal stem cells (MSC) local | phenotype |
| NAD+ | drug |
| Nanodrop | drug |
| Osteoblast local | phenotype |
| Osteopenia local | phenotype |
| osteoporosis | phenotype |
| Osteoporosis pseudo-glioma syndrome (OPPG) local | phenotype |
| PDGF signaling local | phenotype |
| post-treatment weight local | phenotype |
| Ras signaling local | phenotype |
| rats | cohort |
| RiboPure RNA isolation kit local | drug |
| RNA | drug |
| RNase H | drug |
| saline | drug |
| Saline control local | cohort |
| Sprague-Dawley rats | cohort |
| TNFRSF11B | gene |
| total RNA | drug |
| treatment group | cohort |
| TUBB | gene |
| vertebral BMD local | phenotype |
| Vertebral BMD local | phenotype |
| vertebral body area local | phenotype |
| Vertebral bone local | phenotype |
| Vertebral cancellous BMD local | phenotype |
| Vertebral compression fractures local | phenotype |
| vertebral compression strength local | phenotype |
| vertebral compressive strength local | phenotype |
| Vertebral cortical BMD local | phenotype |
| vertebral strength local | phenotype |
| vertebral trabecular BMD local | phenotype |
| Young adult rat model local | cohort |
No uploaded files.
In this knowledge base
| Title | Year | PMID |
|---|---|---|
| Genome-wide association study of alcohol dependence implicates a region on chromosome 11. | 2010 | 20201924 |
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Linking metabolic syndrome with low bone mass through insights from BMI and health behaviors. | Lee CY et al. | β | 2023 | β |
| Bone Marrow Multipotent Mesenchymal Stromal Cells as Autologous Therapy for Osteonecrosis: Effects of Age and Underlying Causes. | El-Jawhari JJ et al. | β | 2021 | β |
| Chronic ethanol consumption does not reduce true bone density in male Wistar rats. | Clayton ZS et al. | β | 2021 | β |
| Alcohol-induced Wnt signaling inhibition during bone fracture healing is normalized by intermittent parathyroid hormone treatment. | Kapania EM et al. | β | 2020 | β |
| Postnatal Ethanol-Induced Neurodegeneration Involves CB1R-Mediated Ξ²-Catenin Degradation in Neonatal Mice. | Subbanna S et al. | β | 2020 | β |
| Cellular and molecular mechanisms of alcohol-induced osteopenia. | Luo Z et al. | β | 2017 | β |
| Alcohol: A Simple Nutrient with Complex Actions on Bone in the Adult Skeleton. | Gaddini GW et al. | β | 2016 | β |
| Alcohol consumption induces global gene expression changes in VTA dopaminergic neurons. | Marballi K et al. | β | 2016 | β |
| Alcohol Regulates BK Surface Expression via Wnt/Ξ²-Catenin Signaling. | VelΓ‘zquez-Marrero C et al. | β | 2016 | β |
| CaMKII represses transcriptionally active Ξ²-catenin to mediate acute ethanol neurodegeneration and can phosphorylate Ξ²-catenin. | Flentke GR et al. | β | 2014 | β |
| Exogenous activation of Wnt/Ξ²-catenin signaling attenuates binge alcohol-induced deficient bone fracture healing. | Lauing KL et al. | β | 2014 | β |
| Identification of gene expression profile in the rat brain resulting from acute alcohol intoxication. | Kong LY et al. | β | 2014 | β |
| Acute alcohol exposure impairs fracture healing and deregulates Ξ²-catenin signaling in the fracture callus. | Lauing KL et al. | β | 2012 | β |
| Aldehyde-stress resulting from Aldh2 mutation promotes osteoporosis due to impaired osteoblastogenesis. | Hoshi H et al. | β | 2012 | β |
| Alcohol exposure and mechanisms of tissue injury and repair. | Jung MK et al. | β | 2011 | β |
| Alcohol induced epigenetic perturbations during the inflammatory stage of fracture healing. | Sampson HW et al. | β | 2011 | β |
| Antioxidant therapy attenuates deficient bone fracture repair associated with binge alcohol exposure. | Volkmer DL et al. | β | 2011 | β |
| Calcium-mediated repression of Ξ²-catenin and its transcriptional signaling mediates neural crest cell death in an avian model of fetal alcohol syndrome. | Flentke GR et al. | β | 2011 | β |
| Effects of nutrition and alcohol consumption on bone loss. | Ronis MJ et al. | β | 2011 | β |
| Inhibition of NADPH oxidases prevents chronic ethanol-induced bone loss in female rats. | Chen JR et al. | β | 2011 | β |
| A role for ethanol-induced oxidative stress in controlling lineage commitment of mesenchymal stromal cells through inhibition of Wnt/beta-catenin signaling. | Chen JR et al. | β | 2010 | β |
| Genome-wide association study of alcohol dependence implicates a region on chromosome 11. | Edenberg HJ et al. | β | 2010 | β |
| Long-term modulations in the vertebral transcriptome of adolescent-stage rats exposed to binge alcohol. | Callaci JJ et al. | β | 2010 | β |
| Binge alcohol-induced bone damage is accompanied by differential expression of bone remodeling-related genes in rat vertebral bone. | Callaci JJ et al. | β | 2009 | β |